Search research articles
Contact Us
Filters
Showing results (371-380 of 427) with videos related to
Page
of 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2011
Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with autologous stem cell transplant in refractory cancer: pharmacokinetic and pharmacodynamic correlates
Janelle B Perkins, Steven C Goldstein, Jana L Dawson, et al.
Bone Marrow Transplantation
|
September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission
G Kunter, J B Perkins, J Pidala, et al.
Journal of Lower Genital Tract Disease
|
August 1, 2020
Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard L Guido, Philip E Castle, et al.
Blood Cancer Journal
|
April 9, 2023
Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
Ahmad Alcheikh, Griffith B Perkins, Phillippa A Pucar, et al.
Journal of Lower Genital Tract Disease
|
January 10, 2025
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines
L Stewart Massad, Megan A Clarke, Rebecca B Perkins, et al.
Journal of Lower Genital Tract Disease
|
September 20, 2021
Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Journal of Lower Genital Tract Disease
|
December 20, 2023
2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Pharmacogenomics
|
January 8, 2024
Association between <i>CYP3A4</i>, <i>CYP3A5</i> and <i>ABCB1</i> genotype and tacrolimus treatment outcomes among allogeneic HSCT patients
Teresa T Ho, Janelle B Perkins, Rebecca Gonzalez, et al.
Journal of Lower Genital Tract Disease
|
April 4, 2020
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Clinical and Translational Medicine
|
May 1, 2024
WNT5B drives osteosarcoma stemness, chemoresistance and metastasis
Rachel S Perkins, Glenn Murray, Sarocha Suthon, et al.
Page
of 43
Search research articles
Search
Showing results (371-380 of 427) with videos related to
Sort By:
Page
of 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2011
Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with autologous stem cell transplant in refractory cancer: pharmacokinetic and pharmacodynamic correlates
Janelle B Perkins, Steven C Goldstein, Jana L Dawson, et al.
Bone Marrow Transplantation
|
September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission
G Kunter, J B Perkins, J Pidala, et al.
Journal of Lower Genital Tract Disease
|
August 1, 2020
Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard L Guido, Philip E Castle, et al.
Blood Cancer Journal
|
April 9, 2023
Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
Ahmad Alcheikh, Griffith B Perkins, Phillippa A Pucar, et al.
Journal of Lower Genital Tract Disease
|
January 10, 2025
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines
L Stewart Massad, Megan A Clarke, Rebecca B Perkins, et al.
Journal of Lower Genital Tract Disease
|
September 20, 2021
Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Journal of Lower Genital Tract Disease
|
December 20, 2023
2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Pharmacogenomics
|
January 8, 2024
Association between <i>CYP3A4</i>, <i>CYP3A5</i> and <i>ABCB1</i> genotype and tacrolimus treatment outcomes among allogeneic HSCT patients
Teresa T Ho, Janelle B Perkins, Rebecca Gonzalez, et al.
Journal of Lower Genital Tract Disease
|
April 4, 2020
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.
Clinical and Translational Medicine
|
May 1, 2024
WNT5B drives osteosarcoma stemness, chemoresistance and metastasis
Rachel S Perkins, Glenn Murray, Sarocha Suthon, et al.
Page
of 43